122 related articles for article (PubMed ID: 32513785)
1. Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study.
Bayraktar S; Baghaki S; Wu J; Liu DD; Gutierrez-Barrera AM; Bevers TB; Valero V; Sneige N; Arun BK
Cancer Prev Res (Phila); 2020 Sep; 13(9):795-802. PubMed ID: 32513785
[TBL] [Abstract][Full Text] [Related]
2. Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study.
Fabian CJ; Nye L; Powers KR; Nydegger JL; Kreutzjans AL; Phillips TA; Metheny T; Winblad O; Zalles CM; Hagan CR; Goodman ML; Gajewski BJ; Koestler DC; Chalise P; Kimler BF
Cancer Prev Res (Phila); 2019 Oct; 12(10):711-720. PubMed ID: 31420361
[TBL] [Abstract][Full Text] [Related]
3. Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer.
Arun B; Valero V; Liu D; Brewster A; Green M; Gutierrez-Barrera A; Akar U; Rivera E; Esteva FJ; Buzdar AU; Hortobagyi GN; Sneige N
Cancer Prev Res (Phila); 2012 Feb; 5(2):276-82. PubMed ID: 22102688
[TBL] [Abstract][Full Text] [Related]
4. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
Fabian CJ; Kimler BF; Zalles CM; Khan QJ; Mayo MS; Phillips TA; Simonsen M; Metheny T; Petroff BK
Breast Cancer Res Treat; 2007 Nov; 106(1):75-84. PubMed ID: 17221152
[TBL] [Abstract][Full Text] [Related]
5. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model.
Fabian CJ; Kimler BF; Zalles CM; Klemp JR; Kamel S; Zeiger S; Mayo MS
J Natl Cancer Inst; 2000 Aug; 92(15):1217-27. PubMed ID: 10922407
[TBL] [Abstract][Full Text] [Related]
6. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
[TBL] [Abstract][Full Text] [Related]
7. Breast cytology and biomarkers obtained by random fine needle aspiration: use in risk assessment and early chemoprevention trials.
Fabian CJ; Zalles C; Kamel S; Zeiger S; Simon C; Kimler BF
J Cell Biochem Suppl; 1997; 28-29():101-10. PubMed ID: 9589354
[TBL] [Abstract][Full Text] [Related]
8. Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812).
Crew KD; Anderson GL; Hershman DL; Terry MB; Tehranifar P; Lew DL; Yee M; Brown EA; Kairouz SS; Kuwajerwala N; Bevers T; Doster JE; Zarwan C; Kruper L; Minasian LM; Ford L; Arun B; Neuhouser M; Goodman GE; Brown PH
Cancer Prev Res (Phila); 2019 Jul; 12(7):481-490. PubMed ID: 31138522
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
[TBL] [Abstract][Full Text] [Related]
10. Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.
Fabian CJ; Kimler BF; Zalles CM; Klemp JR; Petroff BK; Khan QJ; Sharma P; Setchell KD; Zhao X; Phillips TA; Metheny T; Hughes JR; Yeh HW; Johnson KA
Cancer Prev Res (Phila); 2010 Oct; 3(10):1342-50. PubMed ID: 20724470
[TBL] [Abstract][Full Text] [Related]
11. Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer.
Arun BK; Gong Y; Liu D; Litton JK; Gutierrez-Barrera AM; Jack Lee J; Vornik L; Ibrahim NK; Cornelison T; Hortobagyi GN; Heckman-Stoddard BM; Koenig KB; Alvarez RR; Murray JL; Valero V; Lippman SM; Brown P; Sneige N
Breast Cancer Res Treat; 2016 Jul; 158(1):67-77. PubMed ID: 27287781
[TBL] [Abstract][Full Text] [Related]
12. Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal Women.
Fabian CJ; Kimler BF; Phillips TA; Box JA; Kreutzjans AL; Carlson SE; Hidaka BH; Metheny T; Zalles CM; Mills GB; Powers KR; Sullivan DK; Petroff BK; Hensing WL; Fridley BL; Hursting SD
Cancer Prev Res (Phila); 2015 Oct; 8(10):912-21. PubMed ID: 26438592
[TBL] [Abstract][Full Text] [Related]
13. Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer.
Khan QJ; Kimler BF; O'Dea AP; Zalles CM; Sharma P; Fabian CJ
Breast Cancer Res; 2007; 9(3):R35. PubMed ID: 17537236
[TBL] [Abstract][Full Text] [Related]
14. Identification of a chemoprevention cohort from a population of women at high risk for breast cancer.
Fabian CJ; Kamel S; Zalles C; Kimler BF
J Cell Biochem Suppl; 1996; 25():112-22. PubMed ID: 9027607
[TBL] [Abstract][Full Text] [Related]
15. Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.
Fabian CJ; Kimler BF; Donnelly JE; Sullivan DK; Klemp JR; Petroff BK; Phillips TA; Metheny T; Aversman S; Yeh HW; Zalles CM; Mills GB; Hursting SD
Breast Cancer Res Treat; 2013 Nov; 142(1):119-32. PubMed ID: 24141897
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women.
Fabian CJ; Kimler BF; Phillips TA; Nydegger JL; Kreutzjans AL; Carlson SE; Hidaka BH; Metheny T; Zalles CM; Mills GB; Powers KR; Sullivan DK; Petroff BK; Hensing WL; Fridley BL; Hursting SD
Cancer Prev Res (Phila); 2015 Oct; 8(10):922-31. PubMed ID: 26276744
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials.
Arun B; Valero V; Logan C; Broglio K; Rivera E; Brewster A; Yin G; Green M; Kuerer H; Gong Y; Browne D; Hortobagyi GN; Sneige N
Clin Cancer Res; 2007 Aug; 13(16):4943-8. PubMed ID: 17699874
[TBL] [Abstract][Full Text] [Related]
18. A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers.
Fabian CJ; Kimler BF; Brady DA; Mayo MS; Chang CH; Ferraro JA; Zalles CM; Stanton AL; Masood S; Grizzle WE; Boyd NF; Arneson DW; Johnson KA
Clin Cancer Res; 2002 Oct; 8(10):3105-17. PubMed ID: 12374678
[TBL] [Abstract][Full Text] [Related]
19. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
Eng-Wong J; Hursting SD; Venzon D; Perkins SN; Zujewski JA
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739
[TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
Oh H; Pfeiffer RM; Falk RT; Horne HN; Xiang J; Pollak M; Brinton LA; Storniolo AMV; Sherman ME; Gierach GL; Figueroa JD
Int J Cancer; 2018 Aug; 143(3):496-507. PubMed ID: 29473153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
